Glycoprotein IIb/IIIa Inhibitors Use and Outcome after Percutaneous Coronary Intervention for Non-ST Elevation Myocardial Infarction
Figure 2
The unadjusted Kaplan-Meier curves showing cumulative incidence of long-term MACE comparing patients treated with GP IIb/IIIa inhibitors to those not treated with them. MACE were significantly improved amongst patients treated with GP IIb/IIIa inhibitors ().